Cell Lysis/Cell Fractionation Market

Key Players in the Cell lysis Market Focus on Partnerships, Agreements, & Collaborations, Mergers & Acquisitions, New Product Launches, and Expansions

The cell lysis market is consolidated in nature due to the presence of a few large players. The prominent players in the cell lysis market include Beckman Coulter, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Cell Signaling Technology, Inc. (U.S.), F. Hoffman-La Roche AG (Switzerland), Merck KGaA (Germany), Miltenyi Biotec (Germany), QIAGEN N.V. (Netherlands), Qsonica, LLC. (U.S.), and Thermo Fisher Scientific Inc. (U.S.).

Thermo Fisher Scientific Inc. (U.S.) was the global leader in the cell lysis market in 2015. It is a well-known company and has an exhaustive product portfolio. The company is innovation-centric and invests heavily in R&D for maintaining its market share. Moreover, the company focuses on inorganic growth strategies such as acquisitions for enhancing its market share. In February 2013, Thermo Fisher Scientific acquired Life Technologies, a leading player in the life sciences business to expand its product offerings.

Merck KGaA (Germany) held the second position in cell lysis market in 2015 which can be attributed to the strong portfolio of cell lysis products. The company also believes in inorganic growth for boosting its market share. In November 2015, Merck KGaA acquired Sigma-Aldrich Co. LLC (U.S.), a developer of reagents and kits of cell-based research.

The key strategies followed by most companies in the cell lysis market are partnerships, agreements, collaborations; mergers and acquisitions; new product launches; and expansions. The strategy of partnerships, agreements, collaborations accounted for the largest share of the overall growth strategies mapped from 2013 to 2016. Some of the leading players that adopted this strategy include Thermo Fisher Scientific Inc. (U.S), Merck KGaA (Germany), Bio-Rad Laboratory, Inc. (U.S), Beckman Coulter, Inc. (U.S.) and Becton, Dickinson and Company (U.S.) Mergers & Acquisitions accounted for the second-largest share of the overall growth strategies adopted by players in this market.

Related Reports:

Cell Lysis/Cell Fractionation Market by Product (Consumables (Reagents, Enzymes, Detergent), Instruments (Sonicator, Homogenizer)), Type of Cell (Microbial, Mammalian), End User (Research Laboratories, Biopharmaceutical & Biotechnology Companies) - Global Forecasts to 2021

Contact:
Mr. Rohan
Markets and Markets
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune, Maharashtra 411013, India
1-888-600-6441
Email: [email protected]

Report Code
BT 4209
RI Published ON
4/7/2016
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Cell Lysis/Cell Fractionation Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
REQUEST A FREE WORKSHOP
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
ONLINE CHAT
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved